Current filters:


1 to 9 of 25 results

Pharmion to market Refludan outside the USA and Canada


Germany-based Schering AG has entered into an exclusive agreement withPharmion GmbH, a German subsidiary…

Aventis PharmaheparinLepirudinRefludanSchering Ag

FTC orders Aventis to divest Refludan


The US Federal Trade Commission has ordered Aventis to divest itshirudin analog Refludan (lepirudin).…

Aventis PharmaLepirudinRefludan

US FDA issues non-approvable letter for Aventis' Refludan


Aventis Pharmaceuticals of the USA has received a non-approvable letterfrom the US Food and Drug Administration…

Amino AcidsAventis PharmaheparinInjectionLepirudinPhysostigmine SalicylateRefludan

Aventis fails to gain Refludan expanded indication in the USA


The US Food and Drug Administration's Cardiovascular and Renal DrugsAdvisory Committee has voted seven…

Amino AcidsAventis PharmaHamiltonheparinInjectionLepirudinPhysostigmine SalicylateRefludan

BASF ends Ph III trial of ancrod in stroke after questions raised by safety


BASF Pharma says that it has discontinued a Phase III clinical trial ofits fibrinogen-lowering drug Viprinex…

ActivaseAlteplaseAmino AcidsAventis PharmaBASFGenentechheparinInjectionLepirudinPhysostigmine SalicylateRefludan

HMR files Refludan for new indication


Hoechst Marion Roussel has submitted marketing applications to theEuropean Medicines Evaluation Agency…

Amino AcidsheparinInjectionLepirudinPhysostigmine SalicylateRefludan

1 to 9 of 25 results

Back to top